ATE445013T1 - Polypeptide und deren dna - Google Patents

Polypeptide und deren dna

Info

Publication number
ATE445013T1
ATE445013T1 AT00942387T AT00942387T ATE445013T1 AT E445013 T1 ATE445013 T1 AT E445013T1 AT 00942387 T AT00942387 T AT 00942387T AT 00942387 T AT00942387 T AT 00942387T AT E445013 T1 ATE445013 T1 AT E445013T1
Authority
AT
Austria
Prior art keywords
polypeptides
salts
compounds
present
screening
Prior art date
Application number
AT00942387T
Other languages
English (en)
Inventor
Yasuaki Itoh
Kazunori Nishi
Kazuhiro Ogi
Shoichi Ohkubo
Shinichi Mogi
Yuko Noguchi
Koji Yoshimura
Hideyuki Tanaka
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE445013T1 publication Critical patent/ATE445013T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00942387T 1999-06-30 2000-06-29 Polypeptide und deren dna ATE445013T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18671899 1999-06-30
PCT/JP2000/004278 WO2001002564A1 (fr) 1999-06-30 2000-06-29 Nouveau polypeptide et adn de ce polypeptide

Publications (1)

Publication Number Publication Date
ATE445013T1 true ATE445013T1 (de) 2009-10-15

Family

ID=16193433

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00942387T ATE445013T1 (de) 1999-06-30 2000-06-29 Polypeptide und deren dna

Country Status (12)

Country Link
US (1) US6797483B1 (de)
EP (1) EP1191099B1 (de)
KR (1) KR20020026465A (de)
CN (1) CN1359421A (de)
AT (1) ATE445013T1 (de)
AU (1) AU5705600A (de)
CA (1) CA2377791A1 (de)
DE (1) DE60043106D1 (de)
HU (1) HUP0201660A2 (de)
NO (1) NO20016344L (de)
PL (1) PL353065A1 (de)
WO (1) WO2001002564A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166525A1 (en) 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
WO2001055332A2 (en) * 2000-01-25 2001-08-02 Hyseq, Inc. Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
AU2003250547A1 (en) * 2002-08-05 2004-02-23 Asahi Kasei Kabushiki Kaisha Cartilage differentiation inhibiting gene
WO2004015078A2 (en) * 2002-08-08 2004-02-19 Nuvelo, Inc. Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
DK1610822T4 (en) 2003-04-02 2019-01-14 Ares Trading Sa Liquid pharmaceutical FSH and LH formulations together with a nonionic surfactant
CA2526099C (en) 2003-06-20 2013-02-05 Ares Trading Sa Freeze-dried fsh / lh formulations
JP6976254B2 (ja) * 2015-09-18 2021-12-08 バイオネット ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツングBioNet Pharma GmbH Ｃｄ−ｒａｐ前駆体タンパク質の使用による、ｃｄ−ｒａｐの製造方法における発現およびフォールディングの改善

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0710248T3 (da) * 1993-07-20 2000-04-10 Roche Diagnostics Gmbh Melanom-inhiberende protein
AU6030398A (en) * 1997-01-21 1998-08-07 Auckland Uniservices Limited Human proteins
JP2003525568A (ja) * 1997-12-20 2003-09-02 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー 分泌蛋白およびそれらをコードするポリヌクレオチド
AU2225401A (en) * 1999-12-27 2001-07-09 Takeda Chemical Industries Ltd. Novel protein and dna thereof
WO2001055332A2 (en) * 2000-01-25 2001-08-02 Hyseq, Inc. Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
JP6623690B2 (ja) 2015-10-30 2019-12-25 味の素株式会社 グルタミン酸系ｌ−アミノ酸の製造法

Also Published As

Publication number Publication date
AU5705600A (en) 2001-01-22
EP1191099A1 (de) 2002-03-27
EP1191099A4 (de) 2002-08-07
KR20020026465A (ko) 2002-04-10
WO2001002564A1 (fr) 2001-01-11
CN1359421A (zh) 2002-07-17
NO20016344L (no) 2002-02-19
DE60043106D1 (de) 2009-11-19
PL353065A1 (en) 2003-10-06
CA2377791A1 (en) 2001-01-11
HUP0201660A2 (en) 2002-08-28
NO20016344D0 (no) 2001-12-21
EP1191099B1 (de) 2009-10-07
US6797483B1 (en) 2004-09-28

Similar Documents

Publication Publication Date Title
ATE364698T1 (de) Neues, physiologisch aktives peptid und dessen verwendung
DE60037836D1 (de) ThiazoloÄ4,5-dÜpyrimidinverbindungen zur Behandlung von rheumathoider Arthritis
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
WO2000047568A3 (en) 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
DE69725556D1 (de) Flüssige, orale zusammensetzung, welche eine kalziumverbindung und eine säure enthält
DK15589D0 (da) Kemiske forbindelser
NO302474B1 (no) Sakarinderivater, farmasöytisk sammensetning og anvendelse derav
DK2157192T3 (da) Sammensætninger til diagnose og terapi af sygdomme forbundet med afvigende ekspression af futriner (R-spondiner)
ATE311380T1 (de) Durch säuregruppen disubstitierte heteroaryl- derivate und ihre verwendung als matrix metalloproteinas inhibitoren
MA26608A1 (fr) Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque.
KR870700599A (ko) 카르복실산유도체, 그의 제조방법, 이화합물을 함유한 약제조성물 및 그의 용도
DE69531004D1 (de) p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES
SG121733A1 (en) Nucleic acid molecules polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
SE9804212D0 (sv) Compounds
WO2001064877A3 (en) Human schizophrenia gene
DE60043106D1 (de) Polypeptide und deren dna
BR0211635A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de um indivìduo sofrendo de ou propenso à doença de alzheimer
DK383388A (da) 3-demethyl-4-fluor-mevalonsyrederivater, deres fremstilling, farmaceutiske praeparater deraf, deres anvendelse og mellemprodukter til deres fremstilling
BR9811821A (pt) 2-acilaminopropanaminas como antagonistas de receptores de taquicinina
WO2001064876A3 (en) Human schizophrenia gene
DK0552765T3 (da) benzimidazoler, farmaceutiske præparater indeholdende disse og fremgangsmåde til deres fremstilling
EP0915087A3 (de) Sulfonamid-substituierte anellierte 5-Ring-Verbindungen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
EP0913396A3 (de) Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
WO2002062944A3 (fr) Nouveau peptide physiologiquement actif et son utilisation
DK412388D0 (da) Leukotrienantagonister, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse som laegemidler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties